Ryan Crowe is a seasoned investor relations professional currently serving as the Senior Vice President of Investor Relations & Strategic Analysis at Regeneron, a role held since 2024. Previously, Ryan held the position of Vice President of Investor Relations at Regeneron from 2022 to 2024 and at Myovant Sciences from 2020 to 2022. Ryan served as Senior Director of Investor Relations at Pfizer from 2009 to 2020, and earlier roles included Transfer Pricing Analyst and Corporate Tax Analyst. Ryan earned an MBA in Finance from NYU Stern School of Business and a BS in Commerce & Engineering from Drexel University.
This person is not in any teams